Cancer is a leading cause of
death worldwide. According to GLOBOCAN 2012, the incidence of cancer is
expected to increase from 14 Million in 2012 to approximately 21 Million by
2030. Although conventional therapies, such as chemotherapy and radiotherapy, have
been the roots to slow down the progression of tumors, however till date no
complete treatment of this disease is available in the market. Furthermore,
these conventional therapies have numerous side-effects associated with them,
such as nausea, hair loss and abnormal blood cell counts. These limitations and
adverse effects of conventional therapies have therefore created a significant
need for the treatment of cancer. This led to development of new therapies to
curb the prevalence of this disease with minimal side-effects. One such therapy
is cancer immunotherapy, particularly T-cell immunotherapy. T-cell
immunotherapy has shown great promise in the treatment of patients with
late-stage cancer.
View Full Report with TOC @ http://www.radiantinsights.com/research/t-cell-immunotherapy-for-cancer-pipeline-analysis
"T-Cell Immunotherapy for
Cancer - Pipeline Analysis", T-cell
immunotherapy is one of the most widely researched fields in the recent years.
The high potential of T-cell based therapies to cure various types of cancer
indications makes it a popular research area. Numerous researches are being
performed across the globe to explore the potential of T-cell immunotherapy for
the treatment of different therapeutic areas. The rapidly expanding field of
T-cell immunotherapy has experienced clinical successes along with some
critical issues. T-cell immunotherapy has emerged as one of the innovative and
potent arm of the Immunotherapeutics market.
The report provides an in-depth
study on the current state of the T-Cell Immunotherapy industry. Currently,
there is no commercialized T-cell immunotherapy; however due to high venture
capitalist investments and increasing research related activities, this market
is slated to witness a precipitous growth in the coming years. The report
provides detailed analysis of various other factors affecting the growth of the
market.
Request A Sample Copy of This Report at: http://www.radiantinsights.com/research/t-cell-immunotherapy-for-cancer-pipeline-analysis/request-sample
The report also covers the global
as well as regional prevalence of major types of cancer for which T-cell
immunotherapy is used. These cancers include leukemia, lymphoma, melanoma,
ovarian cancer, and bladder cancer amongst others. This will help the companies
to gain knowledge regarding the target population for various immunotherapies
globally, and at regional level.
The report also provides detailed
pipeline analysis of T-cell immunotherapy. In this context, the study provides
a comprehensive overview of various aspects of the clinical trials in the
T-cell immunotherapy market, such as phases, geographies, vectors used,
therapeutic indications, technology types, and key players. The segment also
covers the list of the key ongoing clinical trials along with their clinical
phases. According to the research, CAR-T is the most widely used technology by
the companies. Moreover, the report also suggests that most of the T-cell
immunotherapies are in the research or pre-clinical phase. Limited number of
therapies has been able to cross Phase I of the clinical trials.
Several companies and academic
institutions are operating in this market with a focus on developing T-cell
immunotherapy for 'difficult to treat' cancers. These companies are also
receiving various funding, grants, and investment from non-industry
participants, and other companies and venture capitalist firms, which are
aiding them to develop new products. The report provides details about major
venture capitalist investments, government grants, and IPO raised in this market.
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to
meet their market research and business intelligence requirements. We assist
and facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant
Insights, Inc
Contact Person: Michelle
Thoras
Email:
sales@radiantinsights.com
Phone: (415) 349-0054
Address: 28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Comments
Post a Comment